JPMorgan Chase & Co

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
26,591
Total Value
1174196921659
Accession Number
0000019617-25-000443
Form Type
13F-HR
Manager Name
JPMorgan Chase & Co
Data Enrichment
81% identified
21,604 identified4,987 unidentified

Holdings

26,591 positions
Manager:
Search and click to pin securities to the top
Page 310 of 365
Nuveen Multi-Asset Income Fund
Shares:
1350(+0.0%)
Value:
$16.2M(-0.2%)
Ternium S.A.
Shares:
519(-26.0%)
Value:
$16.2M(-20.7%)
46138E388
Shares:
284
Value:
$16.1M
35473P710
Shares:
870(+57.6%)
Value:
$16.0M(+66.0%)
37954Y699
Shares:
1000
Value:
$15.9M
016255951
Shares:
100(-99.5%)
Value:
$15.9M(-99.7%)
33738R720
Shares:
390(+36.8%)
Value:
$15.9M(+23.3%)
74915M100
Shares:
78367(+28711.4%)
Value:
$15.8M(+17411.1%)
Skye Bioscience, Inc.
Shares:
9904(+7.0%)
Value:
$15.7M(-39.8%)
74347B201
Shares:
467(-41.3%)
Value:
$15.7M(-46.1%)
46137V134
Shares:
990(-21.6%)
Value:
$15.6M(-38.3%)
Werewolf Therapeutics, Inc.
Shares:
16012(-74.5%)
Value:
$15.6M(-83.3%)
TriplePoint Venture Growth BDC Corp.
Shares:
2230(-3.0%)
Value:
$15.6M(-8.3%)
33740F748
Shares:
337
Value:
$15.6M
33939L803
Shares:
207(-84.4%)
Value:
$15.5M(-83.0%)
74933W452
Shares:
308
Value:
$15.4M
46138E404
Shares:
815(+81400.0%)
Value:
$15.4M(+46497.0%)
88634T493
Shares:
745(+2091.2%)
Value:
$15.1M(+1581.0%)
Corvus Pharmaceuticals, Inc.
Shares:
4739(-80.6%)
Value:
$15.1M(-88.5%)
Airsculpt Technologies, Inc.
Shares:
6448(-85.9%)
Value:
$15.1M(-93.7%)